Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
Multiresistant organisms: bacteria and beyond
Curr Opin Organ Transplant. 2022 Mar 11. doi: 10.1097/MOT.0000000000000976. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft dysfunction. Frequently they raise questions about the selection of lung transplant candidates and therapeutic management post lung transplantation. There are no guidelines and management must be individualized. This review summarizes the available therapeutic options in cases of multidrug-resistant (MDR) organisms and outcomes after lung transplant...
Source: Current Opinion in Organ Transplantation - March 14, 2022 Category: Transplant Surgery Authors: Amparo Sole Source Type: research
